Table 3 Demographic and clinical parameters depending on ulcerative colitis extent at diagnosis
From: Factors associated with disease evolution in Greek patients with inflammatory bowel disease
Variable | Proctitis (N = 62) | Left-sided colitis (N = 124) | Extensive colitis (N = 70) | Overall (N = 256) |
|---|---|---|---|---|
Follow-up (yr) | 11.3 ± 7.4 | 12.5 ± 7.1 | 12.5 ± 8.2 | 12.2 ± 7.5 |
Males | 39 (62.9%) | 73 (58.8%) | 42 (60%) | 154 (60.1%) |
Months to diagnosis | 24.6 ± 40 | 8.9 ± 13.7* | 7.7 ± 15.8* | 12.4 ± 24.3 |
Age at diagnosis (yr) | 38.3 ± 14.8 | 43.3 ± 15.6 | 40.3 ± 16.3 | 41.3 ± 15.7 |
Positive family history | 8 (12.9%) | 17 (13.7%) | 9 (12.8%) | 34 (13.2%) |
Current smoking | 16 (25.8%) | 20 (16.1%) | 15 (21.4%) | 51 (19.9%) |
Continuous course | 4 (6.4%) | 9 (7.2%) | 13 (18.5%)*‡ | 26 (10.1%) |
Extraintestinal disease†| 11 (17.7%) | 27 (21.7%) | 16 (22.8%) | 54 (21%) |
Immunosuppressives | 3 (4.8%) | 12 (9.6%) | 16 (22.8%)*‡ | 31 (12.1%) |
Surgery | 0 | 3 (2.4%) | 3 (4.2%) | 6 (2.3%) |